Article
RAB17 promotes endometrial cancer progression by inhibiting TFRC-dependent ferroptosis
6 Sept 2024
Abstract excerpt
Studies have indicated that RAB17 expression levels are associated with tumor malignancy, and RAB17 is more highly expressed in endometrial cancer (EC) tissues than in peritumoral tissues. However, the roles and potential mechanisms of RAB17 in EC remain undefined. The present study confirmed that the expression of RAB17 facilitates EC progression by suppressing cellular ferroptosis-like alterations....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
